Orange Book product · Generic (ANDA)
FLUOCINONIDE
FLUOCINONIDE
At a glance
Feb 10, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 10, 2020
6 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUOCINONIDE
Strength
0.1%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 208989
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUOCINONIDE
- 2005VANOSBrand (NDA)
NDA 021758 · BAUSCH
- 1984FLUOCINONIDEBrand (NDA)
NDA 019117 · SUN PHARMA CANADA
- 1984LIDEXBrand (NDA)
NDA 018849 · ALVOGEN
- —LIDEXBrand (NDA)
NDA 016908 · ALVOGEN
- —FLUOCINONIDEBrand (NDA)
NDA 017373 · ALVOGEN
- —LIDEXBrand (NDA)
NDA 016909 · ALVOGEN
- 2025FLUOCINONIDEGeneric (ANDA)
ANDA 216389 · QUAGEN
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 212976 · XIROMED
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 211758 · ENCUBE
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 207554 · SCIEGEN PHARMS
- 2018FLUOCINONIDEGeneric (ANDA)
ANDA 209699 · ENCUBE ETHICALS
- 2018FLUOCINONIDEGeneric (ANDA)
ANDA 211410 · ENCUBE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
